Innovex Announces First Quarter 2025 Results
First Quarter Highlights
-
Revenue of
$240 million , down 4% quarter over quarter -
Net Income of
$15 million , net income margin of 6% -
Adjusted EBITDA1 of
$46 million and Adjusted EBITDA Margin1 of 19% -
Net Cash Provided by Operating Activities of
$31 million -
Free Cash Flow1 of
$24 million -
Income from Operations of
$22 million - Return on Capital Employed1 of 12%
-
Closed on acquisition of
SCF Machining Corporation (“SCF”) - Completed first successful installation of VXTeTM Self-Orientating Vertical Tree
Key Subsequent Events
-
Entered into a definitive agreement to sell the legacy Dril-Quip Eldridge facility for
$95 million . -
As of
May 5, 2025 , we have repurchased 395,234 shares of Innovex common stock at an average price of$14.94 per share
(1) |
Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP measures. Reconciliations of Adjusted EBITDA to net income, Free Cash Flow to net cash provided by operating activities and ROCE to income from operations, the most directly comparable financial measures presented in accordance with GAAP, are outlined in the reconciliation tables accompanying this release. |
Financial Summary |
||||||||||||||
(in thousands) |
||||||||||||||
Three Months Ended | ||||||||||||||
2025 |
2024 |
2024 |
||||||||||||
Revenue |
$ |
240,415 |
|
$ |
250,687 |
|
$ |
127,997 |
|
|||||
Net Income |
$ |
14,757 |
|
$ |
31,789 |
|
$ |
16,417 |
|
|||||
Net Income Margin |
|
6 |
% |
|
13 |
% |
|
13 |
% |
|||||
Adjusted EBITDA (1) |
$ |
45,921 |
|
$ |
49,063 |
|
$ |
32,505 |
|
|||||
Adjusted EBITDA Margin (1) |
|
19 |
% |
|
20 |
% |
|
25 |
% |
|||||
Net cash provided by operating activities |
$ |
31,090 |
|
$ |
36,345 |
|
$ |
12,605 |
|
|||||
Free Cash Flow (1) |
$ |
24,034 |
|
$ |
28,718 |
|
$ |
10,183 |
|
|||||
Income from operations |
$ |
21,850 |
|
$ |
26,912 |
|
$ |
22,311 |
|
|||||
Twelve Months Ended | ||||||||||||||
2025 |
2024 |
2024 |
||||||||||||
ROCE (1) |
|
12 |
% |
|
12 |
% |
|
20 |
% |
|||||
(1) | Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP financial measures. See definition of these measures and the reconciliation of GAAP to non-GAAP financial measures in the Supplemental Information tables below. |
Operational & Financial Results
Balance Sheet, Debt, Cash Flow & Other
Net cash provided by operating activities was
Innovex generated free cash flow of
Innovex maintains conservative levels of leverage and ample liquidity to maximize strategic flexibility and to capitalize on M&A opportunities that meet our stringent quantitative and qualitative characteristics.
Return on Capital Employed (“ROCE”)
Innovex’s efficient capital allocation and capital-light business model enable the Company to generate strong returns on our invested capital. Income from operations for the twelve months ended
Q2 2025 Guidance
Looking to the second quarter of 2025, Innovex expects to generate
Conference Call Details
Management will host a conference call and a webcast to discuss the financial results on
To access the call, please dial in approximately ten minutes before the start of the call.
Conference Call and Webcast Details
Date / Time:
Webcast: https://events.q4inc.com/attendee/852779315
International Dial-In: +1 (646) 307-1963
Conference ID: 1774704
For those unable to participate in the live call, an audio replay will be available following the call through midnight
About
Our comprehensive portfolio extends throughout the lifecycle of the well, and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer.
With locations throughout
Forward-Looking Statements
Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.
Forward-looking statements can be identified by the use of forward-looking terminology including “may,” “believe,” “expect,” “intend,” “anticipate,” “plan,” “should,” “estimate,” “continue,” “potential,” “will,” “hope” or other similar words and include the Company’s expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other “forward-looking” information, including without limitation statements regarding timing and ability to complete the sale of the Eldridge facility and the expected benefits of such sale. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risks related to the Company’s merger and acquisition activities, including the ultimate outcome and results of integrating operations, the effects of the Company’s merger and acquisition activities (including the Company’s future financial condition, results of operations, strategy and plans), potential adverse reactions or changes to business relationships resulting from the completion of mergers and acquisitions, expected benefits from mergers and acquisition and the ability of the Company to realize those benefits, the significant costs required to integrate operations, whether merger or acquisition-related litigation will occur and, if so, the results of any litigation, settlements and investigations, operating hazards, natural disasters, weather-related delays, casualty losses and other matters beyond our control; acts of terrorism, war or political or civil unrest in
|
|||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Income | |||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
2025 |
2024 |
2024 |
|||||||||||
Revenues |
$ |
240,415 |
|
$ |
250,687 |
|
$ |
127,997 |
|
||||
Cost of revenues |
|
163,911 |
|
|
165,817 |
|
|
78,907 |
|
||||
Selling, general and administrative expenses |
|
32,349 |
|
|
38,278 |
|
|
21,337 |
|
||||
(Gain) loss on sale of assets |
|
148 |
|
|
(167 |
) |
|
(124 |
) |
||||
Depreciation and amortization |
|
14,945 |
|
|
12,039 |
|
|
4,793 |
|
||||
Impairment of long-lived assets |
|
2,924 |
|
|
- |
|
|
- |
|
||||
Acquisition and integration costs |
|
4,288 |
|
|
7,808 |
|
|
773 |
|
||||
Income from operations |
$ |
21,850 |
|
$ |
26,912 |
|
$ |
22,311 |
|
||||
Interest expense |
|
700 |
|
|
375 |
|
|
719 |
|
||||
Other expense (income), net |
|
(214 |
) |
|
700 |
|
|
520 |
|
||||
Equity method earnings |
|
- |
|
|
(386 |
) |
|
(468 |
) |
||||
Reduction of bargain purchase |
|
- |
|
|
6,847 |
|
|
- |
|
||||
Gain on consolidation of equity method investment |
|
- |
|
|
(8,037 |
) |
|
- |
|
||||
Income before income taxes |
$ |
21,364 |
|
$ |
27,413 |
|
$ |
21,540 |
|
||||
Income tax expense (benefit) |
|
6,607 |
|
|
(4,376 |
) |
|
5,123 |
|
||||
Net income |
$ |
14,757 |
|
$ |
31,789 |
|
$ |
16,417 |
|
||||
Foreign currency translation adjustment |
|
4,616 |
|
|
(10,607 |
) |
|
1,030 |
|
||||
Comprehensive income |
$ |
19,373 |
|
$ |
21,182 |
|
$ |
17,447 |
|
||||
Earnings per common share | |||||||||||||
Basic |
$ |
0.21 |
|
$ |
0.47 |
|
$ |
0.53 |
|
||||
Diluted |
$ |
0.21 |
|
$ |
0.47 |
|
$ |
0.51 |
|
||||
Weighted average common shares outstanding | |||||||||||||
Basic |
|
69,290,100 |
|
|
67,889,524 |
|
|
30,978,328 |
|
||||
Diluted |
|
69,477,519 |
|
|
68,044,174 |
|
|
32,292,887 |
|
||||
|
||||||||||
Condensed Consolidated Balance Sheets | ||||||||||
(in thousands) | ||||||||||
(Unaudited) | ||||||||||
2025 |
2024 |
2024 |
||||||||
Assets | ||||||||||
Current assets | ||||||||||
Cash and cash equivalents |
$ |
68,116 |
$ |
73,278 |
$ |
7,635 |
||||
Trade receivable, net |
|
236,020 |
|
239,506 |
|
121,339 |
||||
Inventories, net |
|
269,251 |
|
271,173 |
|
144,466 |
||||
Other current assets |
|
59,251 |
|
57,434 |
|
20,992 |
||||
Total current assets |
|
632,638 |
|
641,391 |
|
294,432 |
||||
Noncurrent assets | ||||||||||
Property and equipment, net |
|
188,426 |
|
190,786 |
|
55,485 |
||||
Equity method investment |
|
- |
|
- |
|
19,435 |
||||
|
|
180,314 |
|
168,539 |
|
63,733 |
||||
Right of use leases - operating, net |
|
56,960 |
|
54,873 |
|
30,895 |
||||
Deferred tax asset, net |
|
128,992 |
|
134,540 |
|
14,694 |
||||
Other long-term assets |
|
8,673 |
|
7,354 |
|
2,140 |
||||
Total noncurrent assets |
|
563,365 |
|
556,092 |
|
186,382 |
||||
Total assets |
$ |
1,196,003 |
$ |
1,197,483 |
$ |
480,814 |
||||
Liabilities and stockholders’ equity | ||||||||||
Current liabilities | ||||||||||
Accounts payable |
$ |
76,391 |
$ |
65,201 |
$ |
36,149 |
||||
Accrued expenses |
|
37,116 |
|
60,593 |
|
23,853 |
||||
Operating lease liabilities |
|
11,535 |
|
10,547 |
|
7,162 |
||||
Other current liabilities |
|
15,221 |
|
15,850 |
|
552 |
||||
Current portion of long-term debt and finance lease obligations |
|
5,556 |
|
10,467 |
|
10,482 |
||||
Total current liabilities |
|
145,819 |
|
162,658 |
|
78,198 |
||||
Noncurrent liabilities | ||||||||||
Long-term debt and finance lease obligations |
|
19,679 |
|
24,901 |
|
32,760 |
||||
Operating lease liabilities |
|
45,962 |
|
45,153 |
|
25,522 |
||||
Other long-term liabilities |
|
6,167 |
|
6,615 |
|
29 |
||||
Total noncurrent liabilities |
|
71,808 |
|
76,669 |
|
58,311 |
||||
Total Liabilities |
$ |
217,627 |
$ |
239,327 |
$ |
136,509 |
||||
Total stockholders’ equity |
$ |
978,376 |
$ |
958,156 |
$ |
344,305 |
||||
Total liabilities and stockholders’ equity |
$ |
1,196,003 |
$ |
1,197,483 |
$ |
480,814 |
||||
|
|||||||||||||
Condensed Consolidated Statement of Cash Flows | |||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
2025 |
2024 |
2024 |
|||||||||||
Cash flows from operating activities | |||||||||||||
Net Income |
$ |
14,757 |
|
$ |
31,789 |
|
$ |
16,417 |
|
||||
Adjustments to reconcile net income to net cash provided by operating activities |
|
29,045 |
|
|
9,782 |
|
|
7,567 |
|
||||
Changes in operating assets and liabilities, net of amounts related to acquisitions |
|
(12,712 |
) |
|
(5,226 |
) |
|
(11,379 |
) |
||||
Net cash provided by operating activities |
$ |
31,090 |
|
$ |
36,345 |
|
$ |
12,605 |
|
||||
Cash flows used in investing activities | |||||||||||||
Payments on acquisitions, net of cash acquired |
$ |
(17,413 |
) |
$ |
(65,521 |
) |
$ |
- |
|
||||
Capital expenditures |
|
(7,056 |
) |
|
(7,627 |
) |
|
(2,422 |
) |
||||
Proceeds from sale of property and equipment |
|
1,003 |
|
|
1,194 |
|
|
194 |
|
||||
Equity method investment |
|
- |
|
|
- |
|
|
- |
|
||||
Cash acquired in stock based business combination |
|
- |
|
|
- |
|
|
- |
|
||||
Net cash used in investing activities |
$ |
(23,466 |
) |
$ |
(71,954 |
) |
$ |
(2,228 |
) |
||||
Cash flows provided by financing activities | |||||||||||||
Net Borrowings (Repayments) on line of credit |
$ |
1,600 |
|
$ |
14,000 |
|
$ |
(7,200 |
) |
||||
Net Repayments on term loan |
|
(11,429 |
) |
|
(1,249 |
) |
|
(1,250 |
) |
||||
Payments on Finance Leases |
|
(1,630 |
) |
|
(1,561 |
) |
|
(1,336 |
) |
||||
Dividend payment |
|
- |
|
|
- |
|
|
- |
|
||||
Other Financing |
|
(1,940 |
) |
|
(50 |
) |
|
(471 |
) |
||||
Net cash provided by (used in) financing activities |
$ |
(13,399 |
) |
$ |
11,140 |
|
$ |
(10,257 |
) |
||||
Effect of exchange rate changes on cash and cash equivalents |
|
613 |
|
|
(2,148 |
) |
|
109 |
|
||||
Net change in cash and cash equivalents |
$ |
(5,162 |
) |
$ |
(26,617 |
) |
$ |
229 |
|
||||
Non-GAAP Measures
Adjusted EBITDA and Adjusted EBITDA Margin
We define Adjusted EBITDA (a non-GAAP measure) as net income before interest expense, income tax expense, depreciation and amortization, (gain)/loss on sale of assets and other expense, net, further adjusted to exclude certain items which we believe are not reflective of our ongoing performance or which are non-cash in nature. Management uses Adjusted EBITDA to assess the profitability of our business operations and to compare our operating performance to our competitors without regard to the impact of financing methods and capital structure and excluding costs that management believes do not reflect our ongoing operating performance. We track Adjusted EBITDA on an absolute dollar basis and as a percentage of revenue, which we refer to as Adjusted EBITDA Margin.
Free Cash Flow
We also utilize Free Cash Flow (a non-GAAP measure) to evaluate the cash generated by our operations and results of operations. We define Free Cash Flow as net cash provided by operating activities less capital expenditures, as presented in our Consolidated Statements of Cash Flows. Management believes Free Cash Flow is useful because it demonstrates the cash that was available in the period that was in excess of our needs to fund our capital expenditures. We track Free Cash Flow both on an absolute dollar basis and as a percentage of revenue. Free Cash Flow does not represent our residual cash flow available for discretionary expenditures, as we have non-discretionary expenditures, including, but not limited to, principal payments required under the terms of our credit facility, which are not deducted in calculating Free Cash Flow.
Return on Capital Employed (ROCE)
We utilize Return on Capital Employed ("ROCE") (a non-GAAP measure) to assess the effectiveness of our capital allocation over time and to compare our capital efficiency to our competitors. We define ROCE as Income from Operations, before acquisition and integration costs and after tax (resulting in Adjusted Income from Operations, after tax) divided by average capital employed. Capital employed is defined as the combined values of debt and stockholders’ equity.
Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and ROCE do not represent and should not be considered alternatives to, or more meaningful than, net income and net cash provided by operating activities, or any other measure of financial performance presented in accordance with GAAP as measures of our financial performance. Our computation of Adjusted EBITDA, Free Cash Flow and ROCE may differ from computations of similarly titled measures of other companies. For a reconciliation of these non-GAAP measures to the most directly comparable GAAP measure, see tables below.
Management has provided outlook regarding Adjusted EBITDA, which is a non-GAAP financial measure and excludes certain charges. A reconciliation of this non-GAAP financial measure to the corresponding GAAP financial measure has not been provided because guidance for the various reconciling items is not provided. The Company is unable to provide guidance for these reconciling items because they cannot determine their probable significance, as certain items are outside of the Company's control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.
|
|||||||||||||
Reconciliation of Net Income to Adjusted EBITDA | |||||||||||||
(in thousands) | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
2025 |
2024 |
2024 |
|||||||||||
Revenue |
$ |
240,415 |
|
$ |
250,687 |
|
$ |
127,997 |
|
||||
Net Income |
$ |
14,757 |
|
$ |
31,789 |
|
$ |
16,417 |
|
||||
Interest expense |
|
700 |
|
|
375 |
|
|
719 |
|
||||
Income tax expense |
|
6,607 |
|
|
(4,376 |
) |
|
5,123 |
|
||||
Depreciation and amortization |
|
14,945 |
|
|
12,039 |
|
|
4,793 |
|
||||
EBITDA |
$ |
37,009 |
|
$ |
39,827 |
|
$ |
27,052 |
|
||||
Other non-operating (income) expense, net (1) |
|
(214 |
) |
|
700 |
|
|
520 |
|
||||
(Gain)/Loss on sale of assets |
|
148 |
|
|
(167 |
) |
|
(124 |
) |
||||
Impairment of long-lived assets |
|
2,924 |
|
|
- |
|
|
- |
|
||||
Acquisition and integration costs (2) |
|
4,288 |
|
|
7,808 |
|
|
773 |
|
||||
Equity Method Adjustment (3) |
|
- |
|
|
661 |
|
|
831 |
|
||||
(Gain on) reduction of bargain purchase |
|
- |
|
|
6,847 |
|
|
- |
|
||||
Gain on consolidation of equity method investment |
|
- |
|
|
(8,037 |
) |
|
- |
|
||||
Stock based compensation |
|
1,766 |
|
|
1,424 |
|
|
468 |
|
||||
IPO Preparation Expenses (4) |
|
- |
|
|
- |
|
|
2,985 |
|
||||
Adjusted EBITDA |
$ |
45,921 |
|
$ |
49,063 |
|
$ |
32,505 |
|
||||
Net Income (Loss) % Revenue |
|
6 |
% |
|
13 |
% |
|
13 |
% |
||||
Adjusted EBITDA Margin |
|
19 |
% |
|
20 |
% |
|
25 |
% |
||||
(1) Primarily represents foreign currency exchange gain/loss, gain/loss on lease terminations, and other non-operating items | |||||||
(2) Consists of legal, accounting, advisory fees, and other integration costs associated with acquisitions, primarily related to |
|||||||
(3) Reflects the elimination of our percentage of interest expense, depreciation, amortization and other non-recurring expenses included within Equity method earnings relating to our unconsolidated investment in DWS. | |||||||
(4) Reflects legal, consulting and accounting fees and expenses related to IPO preparation. | |||||||
|
|||||||||||||
Reconciliation of Income from Operations to ROCE | |||||||||||||
(in thousands) | |||||||||||||
(Unaudited) | |||||||||||||
Twelve Months Ended | |||||||||||||
2025 |
2024 |
2024 |
|||||||||||
Income from operations |
$ |
48,614 |
|
$ |
49,075 |
|
$ |
97,228 |
|
||||
Plus: Acquisition and integration costs |
|
36,815 |
|
|
33,300 |
|
|
2,554 |
|
||||
Less: Income tax expense |
|
(3,971 |
) |
|
(2,487 |
) |
|
(24,709 |
) |
||||
Adjusted income from operations, after tax |
$ |
81,458 |
|
$ |
79,888 |
|
$ |
75,073 |
|
||||
Beginning debt |
$ |
43,242 |
|
$ |
50,390 |
|
$ |
82,799 |
|
||||
Beginning equity |
|
344,305 |
|
|
328,921 |
|
|
270,771 |
|
||||
Ending debt |
|
25,235 |
|
|
35,368 |
|
|
43,242 |
|
||||
Ending equity |
|
978,376 |
|
|
958,156 |
|
|
344,305 |
|
||||
Average capital employed |
$ |
695,579 |
|
$ |
686,418 |
|
$ |
370,559 |
|
||||
ROCE |
|
12 |
% |
|
12 |
% |
|
20 |
% |
||||
|
|||||||||||||
Reconciliation of |
|||||||||||||
(in thousands) | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
2025 |
2024 |
2024 |
|||||||||||
Net cash provided by (used in) operating activities |
$ |
31,090 |
|
$ |
36,345 |
|
$ |
12,605 |
|
||||
Capital expenditures |
$ |
(7,056 |
) |
$ |
(7,627 |
) |
$ |
(2,422 |
) |
||||
Free Cash Flow |
$ |
24,034 |
|
$ |
28,718 |
|
$ |
10,183 |
|
||||
|
||||||||||
Geographic Revenue Details | ||||||||||
(in thousands) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | ||||||||||
2025 |
2024 |
2024 |
||||||||
North America Onshore ("NAM") | ||||||||||
Product revenues |
$ |
75,255 |
$ |
75,397 |
$ |
66,665 |
||||
Rental revenues |
|
28,513 |
|
10,123 |
|
2,107 |
||||
Service revenues |
|
16,749 |
|
17,254 |
|
12,126 |
||||
Revenue - North America Onshore |
$ |
120,517 |
$ |
102,774 |
$ |
80,898 |
||||
International & Offshore | ||||||||||
Product revenues |
$ |
92,095 |
$ |
108,675 |
$ |
40,286 |
||||
Rental revenues |
|
9,491 |
|
17,039 |
|
4,969 |
||||
Service revenues |
|
18,312 |
|
22,199 |
|
1,844 |
||||
Revenue - International & Offshore |
$ |
119,898 |
$ |
147,913 |
$ |
47,099 |
||||
Total Revenue |
$ |
240,415 |
$ |
250,687 |
$ |
127,997 |
||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506582515/en/
Investor Relations Contact
Sr. Director – Investor Relations
investors@innovex-inc.com
(346) 398-0000
Source: